Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol

Digestive Diseases and Sciences

Volumn 42, Issue 4, 1997, Pages 751-761

  Mies, Sérgio ^a   Neto, Oddone Braghirolli ^b   Beer Jr , André ^b   Baîa, Carlos E S ^b   Alfieri Jr , Fernando ^b   Pereira, Leila M M B ^b   Sette, Marcelo J A ^b   Raia, Silvano ^b  

^a NONE   (Brazil)

^b NONE

Author keywords

hemodynamics; Manson's schistosomiasis; portal hypertension; propranolol

Indexed keywords

PROPRANOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEMODYNAMICS; HUMAN; LUNG BLOOD FLOW; MALE; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHISTOSOMIASIS; SPLEEN BLOOD FLOW;

EID: 8244259917     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018803911915     Document Type: Article

References (68)

1. Alves CAP, Alves AR, Abreu WN, Andrade ZA: Hepatic artery hypertrophy and sinusoidal hypertension in advanced schistosomiasis. Gastroenterology 72:126-128, 1977
2. Ramos OL, Saad F, Leser WP: Portal hemodynamics and liver cell function in hepatic schistosomiasis. Gastroenterology 47:241-247, 1964
3. Strauss E, Silva LC, Raia S: Fluxo sangüíneo hepático. Arq Gastroenterol 13:41-50, 1976
4. Raia S, Mies S, Alfieri Jr. F: Portal hypertension in mansonic schistosomiasis. World J Surg 5:176-187, 1991
5. Andrade ZA, Cheever AW: Alterations of the intrahepatic vasculature in nepatosplenic schistosomiasis mansoni. Am J trop Med Hyg 20:425-432, 1971
6. Morgan JS, Groszmann RJ, Rojkind M, Enriquez R: Hemodynamic mechanisms of emerging portal hypertension caused by schistosomiasis in the hamster. Hepatology 11:98-104, 1990
7. Coutinho A: Alterações hemodinâmicas na esquistossomose mansônica hepato-esplênica. J Bras Med 8:299-309, 1964
8. Andrade ZA, Andrade SG: Patologia da esquistossomose hepatesplênica. In Aspectos peculiares da infecçâo por Schistosoma mansoni. ES Azevedo, G Rebouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didático da UFBA, 1984, pp 103-131
9. Lopes de Faria J: Pulmonary arteriovenous fistulas and arterial distribution of eggs of Schistosoma mansoni. Am J trop Med Hyg 5:860-862, 1956
10. Lebrec D, Nouel O, Corbic M, Benhamou JP: Propranolol. A medical treatment for portal hypertension? Lancet 2:180-182, 1980
11. Lebrec D: β-Blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding. Hepatogastroenterology 37:556-560, 1990
12. Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Bermann MM, Patrick MJC, Morse SS, Alberts JL: Shortterm effects of propranolol on portal venous pressure. Hepatology 6:101-106, 1986
13. Rector WG Jr: Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal veins pressure. Arch Intern Med 145:648-650, 1985
14. Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, Audano M: Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 7:648-653, 1987
15. Bosch J, Garcia-Pagán JC, Feu F, Luca A, Fernandez M, Pizcueta P, Rodes J: New approaches in the pharmacological treatment of portal hypertension. J Hepatol 17:841-845, 1993
16. Pagliaro L, D'Amico G, Tine F, Pasta L: Prevention of upper gastrointestinal bleeding from portal hypertension in cirrhosis: rationale for medical treatment. Dig Dis 10:56-64, 1992
17. Acharya SK, Dasarathy S, Saksema S, Pande JH: A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol 19:291-300, 1993
18. Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S: Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol 19:301-311, 1993
19. Mies S, Pereira MB, Orlando CD, Sette M, Raia S: Propranolol na prevençāo da recidiva de hemorragia digestiva em pacientes com esquistossomose hepatesplênica. Rev Assoc Med Bras 34:24-28, 1988
20. Coelho JL: Propranolol em portadores de hipertensāo portal esquistossomótica (estudos hemodinâmicos). Thesis. Faculdade de Medicina, Universidade de Sāo Paulo, Sāo Paulo, 1987
21. Rao PS, Quesada LC, Mueller HS: A simple micromethod for simultaneous determination of plasma propranolol and 4-hydroxypropranolol. Clin Chim Acta 88:355-361, 1978
22. Baselt RC (ed): Propranolol. In Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology. Davis, Biomedical, 1980, pp 248-252
23. Lunderquist A, Vang J: Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 291:646-649, 1974
24. Bosch J, Feu F, Garcia-Pagan JC: Measurement of azygos blood flow. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Spring-Verlag, 1991, pp 139-150
25. Bosch J, Groszmann RJ: Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 4:424-429, 1984
26. Villeneuve JP, Huot R, Marleau D, Huet PM: The estimation of hepatic blood flow with indocyanine green: Comparison between the continuous infusion and single injection methods. Am J Gastroenterol 77:233-237, 1982
27. Barash PG, Kopriva CJ: Cardiac pump function and how to monitor it. In Manual of Cardiac Anesthesia. SJ Thomas (ed). New York, Churchill Livingstone, 1984, pp 1-34
28. Shoemaker WC: Monitoring of the critically ill patient. In Textbook of Critical Care. WC Shoemaker, WL Thompson, PR Holbook (eds). Philadelphia, Saunders, 1984, pp 105-121
29. Ohnishi K, Chin N, Tanaka H, Iida S, Sato S, Terabayashi H, Nomura F: Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension. Am J Gastroenterol 84:409-412, 1989
30. Lautt WW, Greenway CV: Conceptual review of the hepatic vascular bed. Hepatology 7:952-963, 1987
31. Coutinho A: Hemodynamic studies of portal hypertension in schistosomiasis. Am J Med 44:547-556, 1968
32. Carneiro JLA: A circulação colateral gastresofágica após desconexão àzigo-portal. Portografia trans-hepática na esquistossomose mansônica. Thesis. Centro Biomédico Universidade Federal do Espírito Santo, Vitória, 1979
33. Shand DG: Individualization of propranolol therapy. Med Clin North Am 58:1063-1069, 1974
34. Lindenfeld J, Crawford MH, O'Rourke RA, Levine SP, Montiel MM, Hosrwitz LD: Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 62:704-711, 1980
35. Biber B, Holm C, Winsö O, Gustavsson B: Portal blood flow in man during surgery, measured by a modification of the continuous thermodilution method. Scand J Gastroenterol 18:233-239, 1983
36. Fomon JJ, Warren WD: Hemodynamic studies in portal hypertension. Annu Rev 20:277-290, 1969
37. Bosch J, Ginés P, Arroyo V, Navasa M, Rodes J: Hepatic and systemic hemodynamics and the neurohumoral systems in cirrhosis. In The Kidney in Liver Disease, 3rd ed. M Epstein (ed). Baltimore, Williams & Wilkins, 1988, pp 286-305
38. Lebrec D: Hepatic vein catheterization. In Portal Hypertension. Clinical and Phisiological Aspects. K Okuda, J-P Benhamou (ed.s). Tokyo, Springer-Verlag, 1991, pp 117-125
39. Lautt WW, Greenway CV: Hepatic circulation in homeostasis. In The Kidney in Liver Disease, 3rd ed. M Epstein (ed). Baltimore, William; & Wilkins, 1988, pp 244-261
40. Jenkins WJ, Billing B: Physiology of the liver. In Bockus Gastroenterology, Vol 5, 4th ed. JE Berk (ed). Philadelphia, Saunders, 1985, pp 2666-2696
41. Meyers WC: Anatomy and physiology. In Textbook of Surgery, The Biological Basis of Modern Surgical Practice, 13th ed. DC Sahiston Jr (ed). Philadelphia, Saunders, 1986, pp 1053-1068
42. Henderson JM, Warren WD: Surgical complications of cirrhosis and portal hypertension. In Textbook of Surgery. The Biological Basis of Modern Surgical Practice, 13th ed. DC Sabiston Jr (ed). Philadelphia, Saunders, 1986, pp 1095-1116
43. Mahl TC, Groszmann RJ: The pathophysiology of portal hypertension. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Springer-Verlag, 1991, pp 27-33
44. Bradley SE, Ingelfinger FJ, Bradley GP, Curry JJ: The estimation of hepatic blood flow in man. J Clin Invest 24:890-897, 1945
45. Leevy CM, Mendenhall CL, Lesko W, Howard MM: Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169-1180, 1962
46. Rowell LB, Blackmon JR, Bruce RA: Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43:1677-1690, 1964
47. Frishman WH: Pharmacodynamic and pharmacokinetic properties. In Clinical Pharmacology of the Beta-Adrenoceptor Blocking Drugs. WH Frishamn (ed). New York, Appleton, 1980, pp 1-14
48. MacMathuna P, Viavianos P, Wenden J, Gove CD, Westaby D, Williams R: Metabolic effects of β-receptor blockade in advanced alcoholic cirrhosis. J Hepatol 17:74-80, 1993
49. Bendtsen F, Christense NJ, Sörensen TIA, Henriksen JH: Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis. Hepatology 14:237-243, 1991
50. Braillon A, Calès P, Valla D, Gaudy D, Geoffroy P, Lebrec D: Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 27:1204-1209, 1986
51. Schrier RW, Caramelo C: Hemodynamics and hormonal alterations in hepatic cirrhosis. In The Kidney in Liver Disease. M Epstein (ed). Baltimore, Williams & Wilkins, 1988, pp 265-285
52. Bonizon A, Blendis LM: The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 20:1343-1350, 1994
53. Shelmann WH: Hyperdinamic circulation in cirrhosis: A historical perspective. Hepatology 20:1356-1358, 1994
54. MacDougall BRD, Westaby D, Blendis LA: Portal hypertension-25 years of progress. Gut Suppl:S18-S24, 1991
55. Bina JC, Prata A: A evolução natural da esquistossomose mansoni em um área endêmica. In Aspectos peculiarcs da infecção por Schistosoma mansoni. ES Azevedo, G Rebouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didático da UFBA, 1984, pp 13-33
56. Andrade ZA, Andrade SG: Patologia da esquistossomose hepatoesplênica. In Aspectos peculiares da infecção por Schistosoma munsoni. ES Azevedo, G Rehouças, H Rocha, LGC Lyra, RS Teixeira, S Andrade, ZA Andrade (eds). Salvador, Centro Editorial e Didatico da UFBA, 1984, pp 103-131
57. Rivero MA, Marcial MA, Reyes A: Pathology of pulmonary hypertension on Schistosomiasis mansoni. PR Health Sci J 12:43-45, 1993
58. Lopes de Faria J, Barbas JV, Fujioka T, Lion MF, Silva UA, Decourt LV: Pulmonary schistosomatic arteriovenous fistulas producing a new cyanotic syndrome in Manson's schistosomiasis. Am Heart J 58:556-567, 1959
59. Hadengue A, Lebrec D, Benhamou J-P: Pulmonary arterial hypertension in patients with portal hypertension. In Portal Hypertension. Clinical and Physiological Aspects. K Okuda, J-P Benhamou (eds). Tokyo, Springer-Verlag, 1991, pp 401-411
60. Rakela J, Krowka MJ: Cardiovascular and pulmonary complications of liver diseases. In Hepatology. A Textbook of Liver Disease, Vol. 1, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1990, pp 530-537
61. Weiner N: Drugs that inhibit adrcnergic nerves and block adrenergic receptors. In The Goodman and Oilman's Pharmacological Basis of Therapeutics, 7th ed. AG Gilman, LS Goodman, TW Rail, F Murad (eds). New York, Macmillan, 1985, pp 181-214
62. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J: Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol 1:125-139, 1985
63. Calès P, Braillon A, Jirón MI, Lebrec D: Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1:37-46, 1984
64. Kashiwagi T, Kamada T, Abe H: Dynamic studies on the portal hemodynamics by scintiphotosplenoportography. Streamline flow in the human portal vein. Gastroenterology 69:1292-1296, 1975
65. Fausto N: Hepatic regeneration. In Hepatology. A Textbook of Liver Disease, Vol 1, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, Saunders, 1990, pp 49-65
66. Zoller WG, Wagner DR, Zentner J: Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: Assessment by duplex sonography. Z Gastroenterol 31:425-428, 1993
67. Feu F, Bordas JM, Luca A, Garcia-Pagan JC, Escorsell A, Bosch J, Rodés J: Reduction of variceal pressure by propranolol: Comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology 18:1082-1089, 1993
68. Raia S, da Silva LC, Gayotto LCC, Forster SC, Fukushima J, Strauss E: Portal hypertension in schistosomiasis. A long-term follow-up of a randomized trial comparing three types of surgery. Hepatology 20:398-403, 1994